Skip to content
10-K

Annual Report

GeneThera, Inc.

0001199835-21-000184

← back to feed
Filed
Apr 14, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Apr 15, 2021 24.07M sh
Current Liabilities FY 2020 · Dec 31, 2020 $7.69M
Current Liabilities FY 2020 · Dec 31, 2019 $6.94M
Operating Cash Flow restated FY 2020 · Dec 31, 2019 −$269
Total Liabilities FY 2020 · Dec 31, 2019 $6.94M
Current Assets FY 2020 · Dec 31, 2019 $5.31K
Total Assets FY 2020 · Dec 31, 2019 $21.15K
Net Income FY 2020 · Dec 31, 2019 −$517.65K
Operating Income FY 2020 · Dec 31, 2019 −$739.15K
Stockholders Equity restated FY 2020 · Dec 31, 2018 −$6.4M